Vertex Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
22.01.26
/
50%
€391.10
Target price
22.01.27
€467.05
Performance (%)
-1.30%
Price
01.04.26
€386.00
Summary
This prediction is currently active. With a performance of -1.30%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 22.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.088% | -1.088% |
| iShares Core DAX® | 0.751% | -8.496% |
| iShares Nasdaq 100 | -1.405% | -2.771% |
| iShares Nikkei 225® | 0.417% | -9.291% |
| iShares S&P 500 | -0.590% | -2.868% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $546.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€417.90
13.02.26
13.02.26
€455.79
13.02.27
13.02.27
-7.63%
01.04.26
01.04.26
